Association between national action and trends in antibiotic resistance: an analysis of 73 countries from 2000 to 2023
Open Access
- 30 April 2025
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 5 (4) , e0004127
Abstract
The world’s governments have agreed on actions to address the challenge of antibiotic resistance. This raises the question of what level of national action is associated with improved outcomes, including both slower growth and lower levels of antibiotic resistance. Answering this question is challenged by variation in data availability and quality as well as disruptive events such as the COVID-19 pandemic. We investigate the association between level of national action and temporal trends in multiple indicators related to health system capacity, antibiotic use (ABU), absolute rates of resistance (ABR) and a Drug Resistance Index (DRI). Using the Global Database for Tracking Antimicrobial Resistance (TrACSS) to construct an index of national action, we apply cross-sectional regression across 73 countries to estimate the association between the level of action in 2016 and trends in national indicators (2000–2016). We find that national action is consistently associated with improved linear or categorical trends in all groups of indicators. Reductions are associated with a relatively high action index (range 0–4) for ABU (median 2.8, 25–75% quartile 2.6-3.3), ABR (3.0, 2.4-3.4), and DRI (3.5, 3.1-3.6). These associations are robust to the inclusion of other contextual factors related to socio-economic conditions, human population density, animal production and climate. Since 2016, a majority of both Low- and Middle-Income Countries (LMICs) and High-Income Countries (HICs) report increased action on repeated questions, while one third of countries report reduced action. The main limitations in interpretation are heterogeneity in data availability and in when actions have been implemented. Our findings highlight the importance of national action to address the domestic situation related to antibiotic resistance and indicate the value of both incremental changes in reducing adversity of outcomes and the need for high levels of action in delivering reduced levels of resistance.Keywords
All Related Versions
Funding Information
- Erling-Perssons Stiftelse
- HORIZON EUROPE European Research Council (101039376)
- IKEA Foundation
- Marianne and Marcus Wallenberg Foundation
- Uppsala Antibiotic Centre
This publication has 27 references indexed in Scilit:
- Introduction and geographic availability of new antibiotics approved between 1999 and 2014PLOS ONE, 2018
- Global increase and geographic convergence in antibiotic consumption between 2000 and 2015Proceedings of the National Academy of Sciences, 2018
- Antimicrobial resistance: The complex challenge of measurement to inform policy and the publicPLOS Medicine, 2017
- Climatic Drivers of DiarrheagenicEscherichia coliIncidence: A Systematic Review and Meta-analysisThe Journal of Infectious Diseases, 2016
- Access to effective antimicrobials: a worldwide challengeThe Lancet, 2016
- Assessment of empirical antibiotic therapy optimisation in six hospitals: an observational cohort studyThe Lancet Infectious Diseases, 2014
- A mid-term analysis of progress toward international biodiversity targetsScience, 2014
- Communicating trends in resistance using a drug resistance indexBMJ Open, 2011
- The Importance and Future of Antimicrobial Surveillance StudiesClinical Infectious Diseases, 2008
- Comparison of temperature effects on soil respiration and bacterial and fungal growth ratesFEMS Microbiology Ecology, 2005